- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00902629
Epiretinal Fibrosis, Effect of Early Surgery (epitell)
Randomized Clinical Trial Investigating the Longterm Results of Early vs. Delayed Surgery for Epiretinal Fibrosis.
The goal of this randomized clinical trial is to investigate when it is optimal to treat the eye disease epiretinal fibrosis.
Hypothesis: In a population of patients with symptomatic idiopathic epiretinal fibrosis and visual acuity above 0.4, the best long term outcome measured by visual acuity is achieved by early surgery compared to periodic controls until a continual loss of visual acuity has been ensure followed by surgery.
Study Overview
Detailed Description
Epiretinal fibrosis is a disease of the macula, which affects the central retina, and there by the central vision. Epiretinal fibrosis is due to a growth of connective tissue on retinas surface.
From population studies shows that 15% of patients with epiretinal fibrosis will develop moderate to severe loss of visual acuity. Earlier studies have shown that surgery to remove the epiretinal membrane most often leads to improvements in visual acuity if not a normalization of this. The reason why not everyone has normalization of their visual acuity could be growth of connective in the deeper layers of the retina. This intraretinal fibrosis develops over time and is presumed to worsen with the duration of the condition.
In a patient with symptomatic epiretinal fibrosis and visual acuity over 0,4, the current clinical practice is to utilize the wait and see approach, where you hold of treatment until you have made sure that the patients visual acuity is declining. With the wait and see approach you avoid doing surgery on eyes that would have remained stable in their visual acuity. On the other hand will the same approach always ensure that we do surgery on eye that have deteriorated visual acuity, usually to a point of 0,1-0,3 and longer duration of disease.
Hence the results of delayed surgery are presumably worse than what could have been achieved by operating at an earlier point.
This project aims to investigate if you can give the patients a more favorable long term result by doing surgery earlier compared to the traditional wait and see approach.
This study is a prospective randomized clinical trial. We aim to include 60 patients, where 20 will be randomized to early surgery (intervention) and 40 to a close follow-up program(control). If the patients in the control group loss more than 10 Early Treatment Diabetic Retinopathy Study (ETDRS) letters during the follow-up of of they request surgery for their epiretinal fibrosis they will be offered the same operation as the intervention group.
The Intervention group is to have clear lens extraction if they are not already operated for cataract. This is within 4 weeks of inclusion, and another 4 weeks after this they will have their epiretinal fibrosis removed by pars plana vitrectomy.
There are clinical controls after 3,6,9 and 12 months after inclusion/surgery for both groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Copenhagen
-
Glostrup, Copenhagen, Denmark, 2600
- Eye department, Glostrup University hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjective loss of visual acuity and/or visual distortions
- Visual acuity more than or equal to 35 ETDRS letters (at 4 meter)
- Duration of symptoms Less than 13 months
- Metamorphopsia on a Amsler Grid
- Binocular vision disturbed
Exclusion Criteria:
- Diabetic eye symptoms
- Previous oculary surgery, except cataract
- Presence of hard drusen in age-related macular degeneration (AMD)
- Other serious eye diseases
- Patients unable to complete the follow up
- not legal guardian of themselves
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Intervention group contains the patients randomized for early treatment of their epiretinal fibrosis.
|
Intervention group contains patients randomized to receive surgery for their epiretinal fibrosis, at an earlier point than what the common clinical practice is now.
|
No Intervention: Control
Control contains patients not randomized for early surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in best corrected visual acuity, 12 months after enrollment
Time Frame: 12 months after enrollment
|
12 months after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Retinal morphology in the control cohort, 12 months after enrollment
Time Frame: 12 months after enrollement
|
12 months after enrollement
|
Change in subjective quality of life 12 month after enrollment.
Time Frame: 12 months after enrollment
|
12 months after enrollment
|
Changes in visual field 12 months after enrollment
Time Frame: 12 months after enrollment
|
12 months after enrollment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mads Kofod, MD, Eye department, Glostrup University hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPITELL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epiretinal Membrane
-
Medical University of GrazCompletedEpiretinal Membrane of Both EyesAustria
-
Centre Hospitalier Universitaire DijonTerminatedEpiretinal Membrane SurgeryFrance
-
University of RegensburgCompletedIdiopathic Epiretinal Membrane, CataractGermany
-
Centre Hospitalier Universitaire DijonCompletedEpiretinal Membranes
-
Centre Hospitalier Universitaire DijonRecruitingSurgery for Cataract | Surgery for and Idiopathic Epiretinal MembraneFrance
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
The Ludwig Boltzmann Institute of Retinology and...Completed
-
Nantes University HospitalCompleted
-
IRCCS Policlinico S. MatteoCompleted
-
Changhua Christian HospitalCompletedEpiretinal Membrane | Internal Limiting Membrane WrinklingTaiwan
Clinical Trials on Early surgery
-
Asan Medical CenterKorea Institute of MedicineCompletedAortic StenosisKorea, Republic of
-
University of PittsburghMayo Clinic; University of Missouri-Columbia; Washington University School of... and other collaboratorsRecruitingKnee Dislocations | Multiple Ligament Knee InjuriesUnited States
-
Tokyo UniversityCompleted
-
Centre Hospitalier Universitaire de NiceTerminatedObesity | Chronic Kidney DiseaseFrance
-
Asan Medical CenterActive, not recruitingMitral RegurgitationKorea, Republic of
-
Maria Vittoria HospitalMinistry of Health, ItalyTerminated
-
Asan Medical CenterCompletedEndocarditisKorea, Republic of
-
Diakonhjemmet HospitalThe Norwegian Women´s Public Health AssociationUnknown
-
The Hospital for Sick ChildrenMcMaster University; Institute for Clinical Evaluative SciencesCompletedSurgery in Early ChildhoodCanada